FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention concerns an agent on basis of dehydroepiandrosterone (DHEA) for normalising balance of estrogen and androgen in body, characterised by that it contains micronised powder of dehydroepiandrosterone (DHEA) with particle size from 1 to 5 mcm, or its microemulsion with particle size from 2 to 5 mcm and natural chitosan biocompatible nanostructured gel containing DHEA from 5 to 10 mg in 1 ml. Agent is used for menopausal women, as well as for percutaneous administration for elderly.
EFFECT: invention provides improved clinical values in patients of either sex.
3 cl, 6 dwg, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIAGNOSTICS OF AGE ANDROGENIC DEFICIENCY IN WOMEN | 2022 |
|
RU2802126C1 |
PREPARATION AND METHOD FOR THE TREATMENT OF ANDROGEN DEFICIENCY IN WOMEN, ENTOMOLOGICAL CONTAINING PROTEINS | 2015 |
|
RU2577225C1 |
AGENT FOR TREATING HOT FLASHES AND RECUPERATING MENSTRUAL CYCLE DURING PERIMENOPAUSE AND METHOD OF USING IT | 2019 |
|
RU2736997C1 |
LOCAL AND EXTERNAL SYGETHIN-BASED PHARMACEUTICAL COMPOSITION FOR MENOPAUSAL DISORDERS PREVENTION AND TREATMENT | 2007 |
|
RU2356548C1 |
PHARMACEUTICAL PREPARATION FOR EXTERNAL AND LOCAL APPLICATION, BASED ON SYGETHIN | 2007 |
|
RU2363461C2 |
CRYSTALLINE MODIFICATION OF 3β-HYDROXY-5-ANDROSTEN-17-ONE FVII AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2528990C1 |
METHOD FOR REMOTE ELECTROMAGNETIC MULTIWAVE RADIO NEUROENGINEERING OF HUMAN BRAIN | 2015 |
|
RU2621547C2 |
METHOD OF INCREASING MINERAL DENSITY OF BONE TISSUE | 2011 |
|
RU2481815C1 |
PHARMACEUTICAL COMPOSITION BASED ON HUMAN URINE AUTOBIOCOMPONENTS FOR TRANSDERMAL APPLICATION FOR THERAPEUTIC OR COSMETIC PURPOSES | 2020 |
|
RU2751037C1 |
Authors
Dates
2016-07-20—Published
2014-04-24—Filed